BeiGene, Ltd.

NasdaqGS:ONC Stock Report

Market Cap: US$28.0b

BeiGene Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:ONC Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
25 Mar 25SellUS$11,527,575Capital Research and Management CompanyCompany45,777.26US$251.82
04 Mar 25SellUS$2,073,826Xiaodong WangIndividual8,146US$257.41
28 Feb 25SellUS$190,535,020Baker Bros. Advisors LPCompany732,827US$260.00
21 Feb 25SellUS$1,286,174Wang LaiIndividual5,000US$260.17
09 Dec 24SellUS$7,700,043Baker Bros. Advisors LPCompany37,017US$208.01
09 Dec 24SellUS$186,500,000Baker Bros. Advisors LPCompany1,000,000US$186.50
02 Dec 24SellUS$3,568,500,000HHLR Advisors, Ltd.Company17,842,500US$200.00
01 Nov 24SellUS$10,445,631Capital Research and Management CompanyCompany50,971.7US$204.93
08 Oct 24SellUS$2,322,161John OylerIndividual10,000US$236.37
27 Sep 24SellUS$1,101,774Wang LaiIndividual5,000US$220.35
03 Sep 24SellUS$26,022Titus BallIndividual137US$189.94
30 Jul 24SellUS$133,915Chan LeeIndividual834US$160.57
09 Jul 24SellUS$2,422,077Capital Research and Management CompanyCompany218,414.99US$11.09
01 Jul 24SellUS$67,919Julia A. WangIndividual472US$143.90
24 Jun 24SellUS$445,070John OylerIndividual2,789US$160.12
24 Jun 24SellUS$233,133Xiaobin WuIndividual1,459US$161.27
24 Jun 24SellUS$139,938Julia A. WangIndividual899US$155.66
24 Jun 24SellUS$170,030Wang LaiIndividual1,064US$161.10
18 Jun 24SellUS$368,162Wang LaiIndividual2,341US$159.90
18 Jun 24SellUS$505,208Xiaobin WuIndividual3,254US$159.00
17 Jun 24SellUS$69,955Chan LeeIndividual439US$159.74
17 Jun 24SellUS$204,125John OylerIndividual1,281US$159.91
17 Jun 24SellUS$145,678Julia A. WangIndividual916US$159.74

Insider Trading Volume

Insider Buying: ONC insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of ONC?
Owner TypeNumber of SharesOwnership Percentage
Employee Share Scheme138,2400.128%
Private Companies368,3850.342%
Individual Insiders839,7540.779%
Hedge Funds8,803,7258.17%
Public Companies18,938,11917.6%
General Public26,926,65025%
Institutions51,746,29248%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 64.52% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
17.6%
Amgen Inc.
18,938,119US$4.9b0%no data
8.17%
Baker Bros. Advisors LP
8,803,725US$2.3b-7.68%22.33%
5.99%
Capital Research and Management Company
6,452,574US$1.7b-8.77%0.08%
5.66%
HHLR Advisors, Ltd.
6,102,672US$1.6b-28.9%23.31%
4.73%
PRIMECAP Management Company
5,098,904US$1.3b2.51%1.0%
3.56%
Baillie Gifford & Co.
3,836,492US$996.8m-1.46%0.45%
2.89%
BlackRock, Inc.
3,108,941US$807.7m6.5%0.01%
2.73%
T. Rowe Price Group, Inc.
2,937,423US$763.2m8.78%0.07%
2.3%
The Vanguard Group, Inc.
2,475,763US$643.2m1.09%0.01%
1.7%
FMR LLC
1,828,052US$474.9m11.4%0.03%
1.42%
Temasek Holdings (Private) Limited
1,525,329US$396.3m-36.1%0.29%
1.07%
Bosera Asset Management Co., Ltd.
1,150,829US$299.0m0%1.32%
0.96%
Hillhouse Investment Management, Ltd.
1,034,485US$268.8m-72.8%2.42%
0.7%
Xiaodong Wang
756,328US$196.5m-2.62%no data
0.67%
GF Fund Management Co., Ltd.
717,621US$186.4m0.04%0.41%
0.65%
Morgan Stanley, Investment Banking and Brokerage Investments
695,123US$180.6m434%0.02%
0.61%
Invus Financial Advisors, LLC
653,721US$169.8m16.1%9.15%
0.57%
Paradigm Biocapital Advisors LP
616,024US$160.1m208%6.22%
0.51%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
554,319US$144.0m9.68%0.03%
0.4%
China Asset Management Co. Ltd.
427,763US$111.1m-4.54%0.15%
0.37%
ICBC Credit Suisse Asset Management Co., Ltd.
398,099US$103.4m0%0.74%
0.34%
Guangzhou Development District Holding Group Limited
368,385US$95.7m0%no data
0.34%
SDIC Chuangyi Industry Fund Management Co., Ltd.
368,385US$95.7m0%11.38%
0.33%
Public Investment Fund
354,385US$92.1m0%0.02%
0.3%
Candriam, Société En Commandite Par Actions
321,637US$83.6m0%0.23%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/01 21:50
End of Day Share Price 2025/05/01 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BeiGene, Ltd. is covered by 61 analysts. 31 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Brian SkorneyBaird
Michael MengBOCI Research Ltd.
Yonglin YanBOCI Research Ltd.